A double-edged sword; pharmacogenomics
Tracks
3
| Sunday, August 4, 2024 |
| 11:00 AM - 11:40 AM |
| C2.5 + C2.6 |
Details
Pharmacogenomics - a promising miracle; the perfect combination of pharmaceuticals and genetics. This scientific phenomenon enables scientists to use genetic material to create highly personalised medicines. So why is the practice of pharmacogenomics underutilised?
Pharmacogenomics works from the “inside out”, tailoring medicines to be specifically adapted to an individual’s own genetic makeup. Creating such unique and highly personalised medicines can create better health outcomes due to improved safety and efficacy. Additionally, this practice is associated with improvements in drug discovery, improved vaccines and decreased health care costs. However, the challenges and controversies associated with pharmacogenomics are abundant, including a range of social, ethical and clinical concerns.
During this session, we will delve further to understand this evolving concept and consider its role in clinical practice. We will explore emerging technologies including next generation sequencing and drug discovery with specific examples and scenarios you may experience in the pharmacy setting.
Learning objectives
At the end of this session, participants will be able to:
1. Outline the principles of pharmacology and genomics with regards to pharmacogenomics
2. Discuss specific examples and scenarios of pharmacogenomics and it’s implementation into clinical practice
3. Explain the benefits and concerns of implementing the practice of pharmacogenomics into clinical practice.
Competency standards: 1.2, 1.3, 1.4, 3.5, 3.6
Speakers
Dr Sophie Stocker
Senior Lecturer
The University of Sydney
A double edged sword; pharmacogenomics
Biography
Sophie Stocker is a Senior Lecturer in the Sydney Pharmacy School. She is also an Honorary Senior Hospital Scientist in the Department of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney; an Visiting Senior Lecturer of the St Vincent’s Clinical School, University of New South Wales; and an Honorary Scientist at the Garvan Medical Research Institute.Her research program involves clinical and experimental pharmacology, ethnopharmacology, pharmacogenomics, pharmacometrics and qualitative research on the impact of intrinsic and extrinsic factors on drug disposition, efficacy and safety. Her research focuses on understanding variability in response to medicines and how this can be managed to optimise patient care.
